Section 277. Review and reports

1. The commissioner, in consultation with
  the  pharmacy  and  therapeutics  committee,  shall  undertake  periodic
  reviews, at least annually, of the preferred drug  program  which  shall
  include consideration of:
    (a)  the  volume of prior authorizations being handled, including data
  on the number and characteristics of prior  authorization  requests  for
  particular prescription drugs;
    (b) the quality of the program's responsiveness, including the quality
  of the administrator's responsiveness;
    (c) complaints received from patients and providers;
    (d)  the savings attributable to the state, and to each county and the
  city of New York, due to the provisions of this article;
    (e) the aggregate amount  of  supplemental  rebates  received  in  the
  previous  fiscal  year and in the current fiscal year, to date; and such
  amounts are to be broken out by fiscal year and by month;
    (f) the education and outreach  program  established  by  section  two
  hundred seventy-six of this article.
    2. The commissioner and the panel shall, beginning March thirty-first,
  two  thousand  six  and  annually  thereafter,  submit  a  report to the
  governor and the legislature concerning each of  the  items  subject  to
  periodic review under subdivision one of this section.
    3.   The   commissioner  and  the  panel  shall,  beginning  with  the
  commencement of the  preferred  drug  program  and  monthly  thereafter,
  submit  a  report  to  the  governor  and the legislature concerning the
  amount of supplemental rebates received.
    * NB Repealed June 15, 2012